Back
JPMorgan Chase & Co. 10K Form
Buy
53
JPM
JPMorgan Chase & Co.
Last Price:
$296.86
Seasonality Move:
6.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-07-15 | 10K | JPM/JPMorgan Chase & Co. Annual |
| 2025-06-15 | 10K | JPM/JPMorgan Chase & Co. Annual |
| 2025-05-15 | 10K | JPM/JPMorgan Chase & Co. Annual |
| 2025-04-15 | 10K | JPM/JPMorgan Chase & Co. Annual |
| 2025-03-15 | 10K | JPM/JPMorgan Chase & Co. Annual |
| 2025-02-15 | 10K | JPM/JPMorgan Chase & Co. Annual |
Receive JPM News And Ratings
See the #1 stock for the next 7 days that we like better than JPM
JPM Financial Statistics
Sales & Book Value
| Annual Sales: | $280.3B |
|---|---|
| Cash Flow: | $38.1B |
| Price / Cash Flow: | 19.85 |
| Annual Sales: | $126.99 |
| Price / Book: | 2.39 |
Profitability
| EPS (TTM): | 20.01030 |
|---|---|
| Net Income (TTM): | $56.8B |
| Gross Margin: | $0 |
| Return on Equity: | 15.99% |
| Return on Assets: | 1.3% |
JPMorgan Chase & Co. Earnings Forecast
Key JPMorgan Chase & Co. Financial Ratios
-
The Gross Profit Margin over the past 46 years for JPM is 0.00%.
-
The Selling, General & Administrative Expenses for JPM have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of JPM is 20.25% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 31 years.
JPMorgan Chase & Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | JPM |
| CUSIP: | 46625H |
| Website: | jpmorganchase.com |
Debt
| Debt-to-Equity Ratio: | 2.6 |
|---|---|
| Current Ratio: | 1.4 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 15.17 |
|---|---|
| Forward P/E Ratio: | 13.14 |
JPM Technical Analysis vs Fundamental Analysis
Buy
53
JPMorgan Chase & Co. (JPM)
is a Buy
Is JPMorgan Chase & Co. a Buy or a Sell?
-
JPMorgan Chase & Co. stock is rated a BuyThe current JPMorgan Chase & Co. [JPM] share price is $303.63. The Score for JPM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.